Strong expression of CD133 is associated with increased cholangiocarcinoma progression

doi:10.3748/wjg.v17.i9.1192

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3925)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

381

HTML

3047

Figures (1-5)

247

Tables (1-2)

250

Sum=3925

Mar 7, 2011 (publication date) through Feb 6, 2025

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 7, 2011; 17(9): 1192-1198
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1192

Full Size Figure Download Figure

Figure 2 Kaplan-Meier cumulative overall survival curves. A: Survival curves of patients with strong and weak CD133 expression (P = 0.23); B: Survival curves of patients with positive and negative surgical margin status (P = 0.009).

Citation: Leelawat K, Thongtawee T, Narong S, Subwongcharoen S, Treepongkaruna SA. Strong expression of CD133 is associated with increased cholangiocarcinoma progression. World J Gastroenterol 2011; 17(9): 1192-1198
URL: https://www.wjgnet.com/1007-9327/full/v17/i9/1192.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i9.1192